Unique ID issued by UMIN | UMIN000004396 |
---|---|
Receipt number | R000005218 |
Scientific Title | A randomized, multi-center trial to compare the efficacy of once-daily insulin detemir and biphasic insulin aspart-30 in Japanese type 2 diabetes patients with oral hypoglycaemic agents therapy. |
Date of disclosure of the study information | 2010/10/16 |
Last modified on | 2014/04/16 14:17:46 |
A randomized, multi-center trial to compare the efficacy of once-daily insulin detemir and biphasic insulin aspart-30 in Japanese type 2 diabetes patients with oral hypoglycaemic agents therapy.
Once-J Study
A randomized, multi-center trial to compare the efficacy of once-daily insulin detemir and biphasic insulin aspart-30 in Japanese type 2 diabetes patients with oral hypoglycaemic agents therapy.
Once-J Study
Japan |
Type 2 DM
Endocrinology and Metabolism |
Others
NO
Comparison the efficacy and the safety using continuous glucose monitoring (CGM) of once-daily insulin detemir and biphasic insulin aspart-30 in Japanese patients with type 2 diabetes mellitus on monotherapy or combination therapy with sulfonylureas, biguanides and thiazolidinediones.
Safety,Efficacy
24 hour glycemic variations using CGM
Change of HbA1c value
Frequency of hypoglycemia during an observation period
Interventional
Parallel
Randomized
Cluster
Open -no one is blinded
Active
YES
Institution is considered as adjustment factor in dynamic allocation.
2
Treatment
Medicine |
Once-daily insulin detemir
Once-daily biphasic insulin aspart-30
18 | years-old | <= |
Not applicable |
Male and Female
Consent of the participation to this study by a document.
More than three months since subjects were diagnosed as Type 2 diabetes mellitus.
Not having insulin treatment within six months.
HbA1c>8.0%,<10%
BMI<30kg/m2
Monotherapy or combination therapy with oral hypoglycaemic agents
(Sulfonylureas,Thiazolidinediones,Biguanides).
Hypoglycemia
Insulin allergy
having participated in this study in the past
amount of medicine for usage out of an authorized use
Severe retinopathy
Pregnancy
Nursing
Past using Alpha-GIs or Glinides within two months
In addition, Medical attendants judged not to be appropriate as a subject of this study
100
1st name | |
Middle name | |
Last name | Rimei Nishimura |
The Jikei University School of Medicine
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine
3-25-8 Nishishinbashi, Minato-ku, Tokyo, 105-8461, Japan
03-3433-1111(3243)
rimei@yahoo.co.jp
1st name | |
Middle name | |
Last name | Daisuke Tsujino |
The Jikei University School of Medicine
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine
3-25-8 Nishishinbashi, Minato-ku, Tokyo, 105-8461, Japan
03-3433-1111(3243)
dtsujino7777@gmail.com
The Jikei University School of Medicine, Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine
The Jikei University School of Medicine, Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine
Self funding
NO
2010 | Year | 10 | Month | 16 | Day |
Unpublished
Completed
2009 | Year | 10 | Month | 01 | Day |
2010 | Year | 04 | Month | 01 | Day |
2012 | Year | 03 | Month | 31 | Day |
2012 | Year | 03 | Month | 31 | Day |
2012 | Year | 05 | Month | 18 | Day |
2012 | Year | 05 | Month | 18 | Day |
2010 | Year | 10 | Month | 16 | Day |
2014 | Year | 04 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005218